Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate dose-finding sedation study for elderly patients undergoing gastroscopy
ChiCTR2100046877Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (3 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Sedation success rate. Started May 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100046877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046877.